Back to Search
STEPHEN GORE, MD
MD
Emergency Medicine Physician
NPI: 1508807876Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
9400256(NC)0101050730(TN)
Hospitalist Physician
Hospitalist
Code: 208M00000X
0101050730(TN)
Research & Publications (20)
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
PMID 19167676·Biol Blood Marrow Transplant·2009
6-review
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.
PMID 19652201·Blood·2009
3-trial
Design, synthesis and pharmacological screening of novel nitric oxide donors containing 1,5-diarylpyrazolin-3-one as nontoxic NSAIDs.
PMID 19647903·Eur J Med Chem·2009
7-preclinical
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies.
PMID 19546476·Blood·2009
3-trial
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
PMID 19230772·Lancet Oncol·2009
3-trial
Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
PMID 19464085·Eur J Med Chem·2009
8-other
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.
PMID 19109557·Blood·2009
3-trial
Neuronal differentiation in basal cell carcinoma: possible relationship to Hedgehog pathway activation?
PMID 19479712·J Pathol·2009
8-other
Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach.
PMID 19036593·Bioorg Med Chem·2009
7-preclinical
Trends in health sciences library and information science research: an analysis of research publications in the Bulletin of the Medical Library Association and Journal of the Medical Library Association from 1991 to 2007.
PMID 19626146·J Med Libr Assoc·2009
8-other
p21(WAF1/CIP1) induction by 5-azacytosine nucleosides requires DNA damage.
PMID 18223691·Oncogene·2008
8-other
New agents for the treatment of AML recent study findings.
PMID 19205109·Clin Adv Hematol Oncol·2008
8-other
Derepression in the desert: the third workshop on clinical translation of epigenetics in cancer therapeutics.
PMID 18593891·Cancer Res·2008
8-other
Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features.
PMID 18483374·Clin Cancer Res·2008
3-trial
DNA methyltransferase inhibitors: class effect or unique agents?
PMID 18398728·Leuk Lymphoma·2008
4-observational
Comparative modelling by restraint-based conformational sampling.
PMID 18237407·BMC Struct Biol·2008
4-observational
Future directions in myelodysplastic syndrome: newer agents and the role of combination approaches.
PMID 18813208·Cancer Control·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 908 W 4TH NORTH ST, MORRISTOWN-HAMBLEN HOSPITAL
MORRISTOWN, TN 37814 - Phone
- (423) 586-4231
Quick Facts
- NPI
- 1508807876
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile